DUBLIN, Mar. 11, 2014 /PRNewswire/ --
Research and Markets
) has announced the addition of the
report to their offering.
This report analyzes the worldwide markets for Intravenous (IV) Iron Drugs in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
Company profiles are primarily based on public domain information including company URLs. The report profiles 20 companies including many key and niche players such as:
- Actavis, Inc.
- AMAG Pharmaceuticals, Inc.
- Fresenius Medical Care AG & Co.
- KGaA Galenica Ltd.
- Vifor Pharma Ltd.
- Luitpold Pharmaceuticals, Inc.
- American Regent, Inc.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying.
Key Topics Covered:
I. Introduction, Methodology & Product Definitions
II. Executive Summary
2. Industry Overview & Trends
3. Regulatory Overview
4. Overview Of Intravenous (Iv) Iron Drugs
5. Product Launches/Approvals
6. Recent Industry Activity
7. Focus On Select Players
8. Global Market Perspective
1. The United States
6. Latin America
7. Rest Of World
IV. Competitive Landscape
Total Companies Profiled: 20 (including Divisions/Subsidiaries - 22)
- The United States (8)
- Japan (2)
- Europe (4)
- Germany (1)
- Rest of Europe (3)
- Asia-Pacific (Excluding Japan) (8)
For more information visit http://www.researchandmarkets.com/research/dh4l55/intravenous_iv
Media Contact: Laura Wood , +353-1-481-1716, firstname.lastname@example.org
SOURCE Research and Markets